본문으로 건너뛰기
그룹별 보기 기록 1739건 · 페이지 6/35

사용금지 화장품 물질 — 부속서 II

부속서 II는 화장품 원료로 의도적으로 첨가하는 것이 금지된 물질을 나열합니다. 제17조는 별도로, 우수화장품제조관리기준(GMP)과 제3조의 안전 요건에 따라 기술적으로 피할 수 없는 비의도적 미량을 다룹니다. 이 페이지에는 기록 1739건이 있습니다.

이 부속서 필터링

이 부속서의 구성

Annex II is the prohibition list: 1,739 substances that may not be used in cosmetic products in the EU. Article 17 allows for traces that cannot be avoided — it does not allow for adding them.

  • 1,739 prohibited substances, 1,018 of them carrying a CMR classification.
  • Prohibition covers intentional addition; there is no permitted concentration.
  • Article 17 tolerates unintended traces only where they are technically unavoidable under good manufacturing practice and the product remains safe.
  • Absence from Annex II is not permission — most substances appear in no annex at all.

Annex II is the shortest kind of answer the regulation gives. A substance listed here may not be used as a cosmetic ingredient, and there is no concentration at which that changes. Where other annexes set limits and conditions, this one sets none, because there is nothing to condition.

The nuance people look for lives in Article 17 rather than in the annex. It provides that the unintended presence of a small quantity of a prohibited substance is permitted where it is technically unavoidable under good manufacturing practice and the product remains safe under Article 3. That is a provision about impurities and residues — what arrives with a raw material, what forms during manufacture, what migrates from packaging. It is not a tolerance to formulate against, and a deliberate addition at a low level is not covered by it.

Just over a thousand of these entries carry a CMR classification — carcinogenic, mutagenic or toxic for reproduction under the CLP Regulation. That is the route by which most of them arrived: Article 15 prohibits CMR substances in cosmetics, with a narrow derogation procedure that is rarely used, so a CLP classification generally becomes an Annex II entry in due course.

The most common misreading is the opposite of the list's own logic. A substance not found in Annex II has not been assessed and permitted. It has not been assessed at all. Most cosmetic ingredients appear in no annex, and their acceptability rests on the safety assessment the responsible person is required to hold.

대조 대상

부속서 II 기록

1739 총
이 목록의 기록, 총 1739건
항목물질CAS최대 농도표시
251Nitrofurantoin (INN)CAS 67-20-9 67-20-9 —
252Furazolidone (INN)CAS 67-45-8 67-45-8 —
253NitroglycerinPropane-1,2,3-triyl trinitrateCAS 55-63-0 55-63-0 —
254Acenocoumarol (INN)CAS 152-72-7 152-72-7 —
255Alkali pentacyanonitrosylferrate (2-)CAS 14402-89-2 / 13755-38-9 14402-89-2 / 13755-38-9 —
256Nitrostilbenes, their homologues and their derivatives——
257Noradrenaline and its saltsCAS 51-41-2 51-41-2 —
258Noscapine (INN) and its saltsCAS 128-62-1 128-62-1 —
259Guanethidine (INN) and its saltsCAS 55-65-2 55-65-2 —
260Oestrogens——
261OleandrinCAS 465-16-7 465-16-7 —
262Chlortalidone (INN)CAS 77-36-1 77-36-1 —
263Pelletierine and its saltsCAS 2858-66-4 / 4396-01-4 2858-66-4 / 4396-01-4 —
264PentachloroethaneCAS 76-01-7 76-01-7 —CMR
265Pentaerithrityl tetranitrate (INN)CAS 78-11-5 78-11-5 —
266Petrichloral (INN)CAS 78-12-6 78-12-6 —
267Octamylamine (INN) and its saltsCAS 502-59-0 502-59-0 —
268Picric acidCAS 88-89-1 88-89-1 —
269Phenacemide (INN)CAS 63-98-9 63-98-9 —
270Difencloxazine (INN)CAS 5617-26-5 5617-26-5 —
2712-Phenylindan-1,3-dione (Phenindione (INN))CAS 83-12-5 83-12-5 —
272Ethylphenacemide (pheneturide (INN))CAS 90-49-3 90-49-3 —
273Phenprocoumon (INN)CAS 435-97-2 435-97-2 —
274Fenyramidol (INN)CAS 553-69-5 553-69-5 —
275Triamterene (INN) and its saltsCAS 396-01-0 396-01-0 —
276Tetraethyl pyrophosphate (TEPP - ISO)CAS 107-49-3 107-49-3 —
277Tritolyl phosphateCAS 1330-78-5 1330-78-5 —
278Psilocybine (INN)CAS 520-52-5 520-52-5 —
279Phosphorus and metalphosphidesCAS 7723-14-0 7723-14-0 —
280Thalidomide (INN) and its saltsCAS 50-35-1 50-35-1 —
281Physostigma venenosum Balf.CAS 89958-15-6 89958-15-6 —
282PicrotoxinCAS 124-87-8 124-87-8 —
283Pilocarpine and its saltsCAS 92-13-7 92-13-7 —
284alpha-Piperidin-2-ylbenzyl acetate, laevorotatory threoform (levofacetoperane (INN)) and its saltsCAS 24558-01-8 24558-01-8 —
285Pipradrol (INN) and its saltsCAS 467-60-7 467-60-7 —
286Azacyclonol (INN) and its saltsCAS 115-46-8 115-46-8 —
287Bietamiverine (INN)CAS 479-81-2 479-81-2 —
288Butopiprine (INN) and its saltsCAS 55837-15-5 55837-15-5 —
289Lead and its compoundsCAS 7439-92-1 7439-92-1 —
290ConiineCAS 458-88-8 458-88-8 —
291Prunus laurocerasus L. ("cherry laurel water")CAS 89997-54-6 89997-54-6 —
292Metyrapone (INN)CAS 54-36-4 54-36-4 —
293Radioactive substances, as defined by Directive 96/29/Euratom (1) laying down the basic safety standards for the protection of the health of workers and the general public against the dangers arising from ionising radiation——
294Juniperus sabina L. (leaves, essential oil and galenical preparations)CAS 90046-04-1 90046-04-1 —
295Hyoscine, its salts and derivativesCAS 51-34-3 51-34-3 —
296Gold salts——
297Selenium and its compounds with the exception of selenium disulphide under the conditions set out under reference No 49 in Annex IIICAS 7782-49-2 7782-49-2 —
298Solanum nigrum L. and its galenical preparationsCAS 84929-77-1 84929-77-1 —
299Sparteine (INN) and its saltsCAS 90-39-1 90-39-1 —
300Glucocorticoids (Corticosteroids)——

이 그룹별 보기 사용 방법

부속서 II에는 화장품에 사용이 금지된 물질이 포함되어 있습니다. 사용금지 물질 기록 1739건을 명칭, 식별자 및 연결된 항목 페이지별로 빠르게 훑어보려면 이 그룹별 보기를 이용하세요.

법적 문구 전문, 농도 논리, 경고 문구 또는 관련 식별자 링크가 필요하면 개별 기록을 여세요.